Evaluation of the clinical implementation of a tattoo-free positioning technique in breast cancer radiotherapy using ExacTrac.

PURPOSE: Conventionally, tattoos and temporary skin marks are used in patient positioning procedures for breast cancer radiotherapy. However, many patients dislike these marks because their daily lives are affected by them. Therefore, we developed a new positioning technique using ExacTrac (BrainLAB AG, Munich, Germany). This study aimed to evaluate the clinical implementation of a tattoo-free positioning technique for breast cancer radiotherapy using ExacTrac. METHODS: We included 35 patients with breast cancer, 14 with tattoo-based positioning and 21 with tattoo-free positioning using ExacTrac. In this ExacTrac-based positioning technique, the patients were aligned around the mamilla of the ipsilateral breast, and 6D registration was performed later at the virtual isocenter, which was placed at the spinal cord. The target displacement relative to the treatment isocenter was identified and then compensated for using robotic couch translations and rotations. The gamma index method analyzes the integrated dose images of the transmitted radiation dose through patients to investigate the irradiation accuracy of the two positioning techniques. The clinical implementation of the ExacTrac-based positioning technique was evaluated by comparing the gamma passing rate of the tattoo-based and ExacTrac-based positioning techniques. RESULTS: The mean gamma passing rates of the tattoo-based and ExacTrac-based positioning techniques were 86.0 ± 10.2% and 90.9 ± 6.9%, respectively. CONCLUSION: The ExacTrac-based positioning technique provided positioning comparable to that of the tattoo-based positioning technique. Consequently, the clinical implementation of the tattoo-free positioning technique in breast cancer radiotherapy using ExacTrac was demonstrated.

Dosimetric impacts of beam-hardening filter removal for the CyberKnife system.

PURPOSE: Equipment refurbishment was performed to remove the beam-hardening filter (BHF) from the CyberKnife system (CK). This study aimed to confirm the change in the beam characteristics between the conventional CK (present-BHF CK) and CK after the BHF was removed (absent-BHF CK) and evaluate the impact of BHF removal on the beam quality correction factors kQ. METHODS: The experimental measurements of the beam characteristics of the present- and absent-BHF CKs were compared. The CKs were modeled using Monte Carlo simulations (MCs). The energy fluence spectra were calculated using MCs. Finally, kQ were estimated by combining the MC results and analytic calculations based on the TRS-398 and TRS-483 approaches. RESULTS: All gamma values for percent depth doses and beam profiles between each CK were less than 0.5 following the 3%/1 mm criteria. The percentage differences for tissue-phantom ratios at depths of 20 and 10 cm and percentage depth doses at 10 cm between each CK were -1.20% and -0.97%, respectively. The MC results demonstrated that the photon energy fluence spectrum of the absent-BHF CK was softer than that of the present-BHF CK. The kQ values for the absent-BHF CK were in agreement within 0.02% with those for the present-BHF CK. CONCLUSIONS: The photon energy fluence spectrum was softened by the removal of BHF. However, no remarkable impact was observed for the measured beam characteristics and kQ. Therefore, the previous findings of the kQ values for the present-BHF CK can be directly used for the absent-BHF CK.

Stereotactic body radiation therapy for Japanese patients with localized prostate cancer: 2-year results and predictive factors for acute genitourinary toxicities.

OBJECTIVE: We aimed to report the 2-year results of stereotactic body radiation therapy for prostate cancer and identify the clinical and dosimetric factors that predict acute genitourinary toxicities. METHODS: We retrospectively reviewed the medical records of patients with non-metastatic prostate cancer treated at Toyota Memorial Hospital between 2017 and 2020. The patients were treated with stereotactic body radiation therapy with a total dose of 36.25 Gy in five fractions on consecutive weekdays. While low-risk patients received radiotherapy alone, intermediate- to high-risk patients also received androgen deprivation therapy. RESULTS: We analysed a total of 104 patients, including 10, 60 and 34 low-, intermediate- and high-risk patients, respectively. The median follow-up duration was 2 years. We did not observe biochemical/clinical recurrence, distant metastasis or death from prostate cancer. One patient died of another cause. Grade 2 acute genitourinary toxicity was observed in 40 (38%) patients. Age (P = 0.021), genitourinary toxicity of grade ≥1 at baseline (P = 0.023) and bladder mean dose (P = 0.047) were significantly associated with the incidence of grade 2 acute genitourinary toxicity. The cut-off value of 65 years for age and 10.3 Gy for the bladder mean dose were considered the most appropriate. Grade 2 acute gastrointestinal toxicity was observed in five (5%) patients. None of the patients experienced grade ≥3 acute or late toxicity. CONCLUSIONS: Stereotactic body radiation therapy is feasible for Japanese patients with prostate cancer, with acceptable acute toxicity. Age, genitourinary toxicity at baseline and bladder mean dose predict grade 2 acute genitourinary toxicity.

Beam Characterization of 10-MV Photon Beam from Medical Linear Accelerator without Flattening Filter.

AIM: This work investigated the dosimetric properties of a 10-MV photon beam emitted from a medical linear accelerator (linac) with no flattening filter (FF). The aim of this study is to analyze the radiation fluence and energy emitted from the flattening filter free (FFF) linac using Monte Carlo (MC) simulations. MATERIALS AND METHODS: The FFF linac was created by removing the FF from a linac in clinical use. Measurements of the depth dose (DD) and the off-axis profile were performed using a three-dimensional water phantom with an ionization chamber. A MC simulation for a 10-MV photon beam from this FFF linac was performed using the BEAMnrc code. RESULTS: The off-axis profiles for the FFF linac exhibited a chevron-like distribution, and the dose outside the irradiation field was found to be lower for the FFF linac than for a linac with an FF (FF linac). The DD curves for the FFF linac included many contaminant electrons in the build-up region. CONCLUSION: Therefore, for clinical use, a metal filter is additionally required to reduce the effects of the electron contamination. The mean energy of the FFF linac was found to be lower than that of the FF linac owing to the absence of beam hardening caused by the FF.

[Detailed analysis of multi-leaf collimator movement during radiation delivery using an in-house-developed program].

Multi-leaf collimators (MLCs) are used to modulate intensity during intensity modulated radiation therapy (IMRT). Evaluation of MLC movement in IMRT is important, since the accuracy of MLC movements affects the dose distribution. This evaluation is conventionally performed using an attached Dynalog File Viewer (DFV). However, due to its being an overall evaluation, it is not possible to discover significant errors. In this study, we developed software that permits easy analysis of MLC movements that can be used to retrospectively evaluate MLC movement during irradiation. We also evaluated the usefulness of our in-house program and confirmed its potential for use in clinical scenarios. We created a program that can read MLC logfiles using Visual Basic 6.0 and visualize the temporal changes and movements of the MLC. To evaluate our in-house program's efficacy in analyzing dynamic MLC-QA (quality assurance), we compared the numerical results yielded by our in-house program and the DFV. The results showed that our in-house program was able to reveal errors below the error root mean square (RMS) values obtained using the DFV. Using irregular surface compensator (ISC) irradiation conditions in a clinical context, we compared our in-house program with the DFV and, using RMS analysis, identified cases that showed excessive error. Our in-house program can also be used to investigate whether unacceptable errors are present, as well as their cause, when using the MLC, as it allows easy real-time observation and evaluation of MLC movements. An additional benefit is that collecting the MLC logfile during actual treatment also allows it to be evaluated retrospectively after continuous MLC operation.